Díaz-Rodríguez E - Search Results

1

Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis.

Ollauri-Ibáñez C, Núñez-Gómez E, Egido-Turrión C, Silva-Sousa L, Díaz-Rodríguez E, Rodríguez-Barbero A, López-Novoa JM, Pericacho M. Ollauri-Ibáñez C, et al. Angiogenesis. 2020 May;23(2):231-247. doi: 10.1007/s10456-019-09703-y. Epub 2020 Jan 3. Angiogenesis. 2020. PMID: 31897911 Free PMC article.

2

Neuregulins and cancer.

Montero JC, Rodríguez-Barrueco R, Ocaña A, Díaz-Rodríguez E, Esparís-Ogando A, Pandiella A. Montero JC, et al. Clin Cancer Res. 2008 Jun 1;14(11):3237-41. doi: 10.1158/1078-0432.CCR-07-5133. Clin Cancer Res. 2008. PMID: 18519747 Review.

3

Central Role of Cell Cycle Regulation in the Antitumoral Action of Ocoxin.

Pérez-Peña J, Díaz-Rodríguez E, Sanz E, Pandiella A. Pérez-Peña J, et al. Nutrients. 2019 May 14;11(5):1068. doi: 10.3390/nu11051068. Nutrients. 2019. PMID: 31091680 Free PMC article.

4

Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanisms.

Ríos-Luci C, Díaz-Rodríguez E, Gandullo-Sánchez L, Díaz-Gil L, Ocaña A, Pandiella A. Ríos-Luci C, et al. Cancer Lett. 2020 Feb 1;470:161-169. doi: 10.1016/j.canlet.2019.11.026. Epub 2019 Nov 22. Cancer Lett. 2020. PMID: 31765734

5

Resistance to the Antibody-Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity.

Ríos-Luci C, García-Alonso S, Díaz-Rodríguez E, Nadal-Serrano M, Arribas J, Ocaña A, Pandiella A. Ríos-Luci C, et al. Cancer Res. 2017 Sep 1;77(17):4639-4651. doi: 10.1158/0008-5472.CAN-16-3127. Epub 2017 Jul 7. Cancer Res. 2017. PMID: 28687619

6

TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells.

Díaz-Rodríguez E, Pérez-Peña J, Ríos-Luci C, Arribas J, Ocaña A, Pandiella A. Díaz-Rodríguez E, et al. Cancer Lett. 2019 Jul 1;453:34-44. doi: 10.1016/j.canlet.2019.03.042. Epub 2019 Mar 27. Cancer Lett. 2019. PMID: 30928382

7

Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease.

Garcia-Gomez A, De Las Rivas J, Ocio EM, Díaz-Rodríguez E, Montero JC, Martín M, Blanco JF, Sanchez-Guijo FM, Pandiella A, San Miguel JF, Garayoa M. Garcia-Gomez A, et al. Oncotarget. 2014 Sep 30;5(18):8284-305. doi: 10.18632/oncotarget.2058. Oncotarget. 2014. PMID: 25268740 Free PMC article.

8

Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer.

Díaz-Rodríguez E, Sanz E, Pandiella A. Díaz-Rodríguez E, et al. Int J Oncol. 2018 Jul;53(1):113-123. doi: 10.3892/ijo.2018.4373. Epub 2018 Apr 16. Int J Oncol. 2018. PMID: 29658597 Free PMC article.

9

Antitumoral effect of Ocoxin on acute myeloid leukemia.

Díaz-Rodríguez E, Hernández-García S, Sanz E, Pandiella A. Díaz-Rodríguez E, et al. Oncotarget. 2016 Feb 2;7(5):6231-42. doi: 10.18632/oncotarget.6862. Oncotarget. 2016. PMID: 26756220 Free PMC article.

10

Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review.

Pandiella-Alonso A, Díaz-Rodríguez E, Sanz E. Pandiella-Alonso A, et al. Among authors: diaz rodriguez e. Nutrients. 2020 Aug 31;12(9):2661. doi: 10.3390/nu12092661. Nutrients. 2020. PMID: 32878230 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page